Seroatlas · Human Serome Atlas

IGFBP1

Insulin-like growth factor-binding protein 1

Also known as: AFBP, hIGFBP-1, IBP1, IBP1_HUMAN, IGF-BP25, PP12

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P08833
Gene
IGFBP1
Ensembl
ENSG00000146678
Chromosome
7
Canonical length
259 aa
Protein class
Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins
Subcellular location
Golgi apparatus
Secretome location
Secreted to blood

OverviewNCBI Gene

This gene is a member of the insulin-like growth factor binding protein (IGFBP) family and encodes a protein with an IGFBP N-terminal domain and a thyroglobulin type-I domain. The encoded protein, mainly expressed in the liver, circulates in the plasma and binds both insulin-like growth factors (IGFs) I and II, prolonging their half-lives and altering their interaction with cell surface receptors. This protein is important in cell migration and metabolism. Low levels of this protein may be associated with impaired glucose tolerance, vascular disease and hypertension in human patients. [provided by RefSeq, Aug 2017]

Canonical amino-acid sequenceUniProt

259 residues, UniProt reviewed canonical sequence.

>P08833|IGFBP1
     1  MSEVPVARVW LVLLLLTVQV GVTAGAPWQC APCSAEKLAL CPPVSASCSE VTRSAGCGCC
    61  PMCALPLGAA CGVATARCAR GLSCRALPGE QQPLHALTRG QGACVQESDA SAPHAAEAGS
   121  PESPESTEIT EEELLDNFHL MAPSEEDHSI LWDAISTYDG SKALHVTNIK KWKEPCRIEL
   181  YRVVESLAKA QETSGEEISK FYLPNCNKNG FYHSRQCETS MDGEAGLCWC VYPWNGKRIP
   241  GSPEIRGDPN CQIYFNVQN

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against IGFBP1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Secreted
Secreted
Yes
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.44
Highest tissue expression
1,121 nTPM

Expression across tissuesHPA

Tissue

  • liver: 1,121 nTPM
  • placenta: 192 nTPM
  • endometrium: 75 nTPM
  • ovary: 46 nTPM
  • fallopian tube: 3.8 nTPM
  • adipose tissue: 2.7 nTPM

Single-cell type

  • hepatocytes: 1,210 nCPM
  • decidual stromal cells: 1,197 nCPM
  • endometrial stromal cells: 69 nCPM
  • fallopian tube ciliated cells: 43 nCPM
  • cholangiocytes: 28 nCPM
  • myosatellite cells: 23 nCPM

Immune cell

  • basophil: 0 nTPM
  • classical monocyte: 0 nTPM
  • eosinophil: 0 nTPM
  • gdT-cell: 0 nTPM
  • intermediate monocyte: 0 nTPM
  • MAIT T-cell: 0 nTPM

Brain region

  • pons: 2 nTPM
  • medulla oblongata: 1.4 nTPM
  • cerebral cortex: 0.7 nTPM
  • hypothalamus: 0.7 nTPM
  • midbrain: 0.7 nTPM
  • thalamus: 0.7 nTPM

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.19
gnomAD pLI
0
gnomAD missense Z
0.25
DepMap mean gene effect
-0.07
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of IGFBP1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads IGFBP1 as an antibody target. Whether an autoantibody or antibody against IGFBP1 could matter depends on whether native IGFBP1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

IGFBP1 is annotated as secreted, so native IGFBP1 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.

Annotation status

The present source text does not explicitly label IGFBP1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/IGFBP1. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...